Lucid Diagnostics Inc (LUCD)
Healthcare
Medical Devices
0.87 $
-3.3%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Lucid Diagnostics Inc (LUCD)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 73.7% of the shares are freely tradable; institutional investors hold 19.4%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
19.4%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
26.5%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
73.7%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
4.8%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
191Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Group Inc | 2.60 | 4,968,608 | +9.8 | 12/31/2025 |
| BlackRock Inc | 2.43 | 4,638,243 | +7.6 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.18 | 4,154,770 | +0.0 | 03/31/2026 |
| Masters Capital Management LLC | 2.10 | 4,000,000 | +0.0 | 03/31/2026 |
| Aberdeen Group PLC | 1.91 | 3,644,277 | +5.4 | 03/31/2026 |
| Two Seas Capital LP | 1.57 | 3,000,000 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 1.18 | 2,245,350 | +10.8 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| abrdn Healthcare Opportunities | 1.84 | 3,514,366 | -3.6 | 04/30/2026 |
| Vanguard Total Stock Mkt Idx Inv | 1.59 | 3,025,302 | +0.0 | 04/30/2026 |
| iShares Russell 2000 ETF | 1.12 | 2,139,890 | +0.9 | 05/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.